Affiliation:
1. Department of Nutrition and Health, China Agricultural University, Beijing 100193, China
2. Key Laboratory of Precision Nutrition and Food Quality, China Agricultural University, Beijing 100193, China
Abstract
Photodynamic therapy (PDT) is an effective method for treating microbial infections by leveraging the unique photophysical properties of photosensitizing agents, but issues such as fluorescence quenching and the restricted generation of reactive oxygen species (ROS) under hypoxic conditions still remain. In this study, we successfully synthesized and designed a coumarin-based aggregation-induced emission luminogen (AIEgen), called ICM, that shows a remarkable capacity for type I ROS and type II ROS generation. The 1O2 yield of ICM is 0.839. The ROS it produces include hydroxyl radicals (HO•) and superoxide anions (O2•−), with highly effective antibacterial properties specifically targeting Staphylococcus aureus (a Gram-positive bacterium). Furthermore, ICM enables broad-spectrum fluorescence imaging and exhibits excellent biocompatibility. Consequently, ICM, as a potent type I photosensitizer for eliminating pathogenic microorganisms, represents a promising tool in addressing the threat posed by these pathogens.
Funder
Natural Science Foundation of China
Chinese Universities Scientific Fund
Reference41 articles.
1. Maltotriose-based probes for fluorescence and photoacoustic imaging of bacterial infections;Zlitni;Nat. Commun.,2020
2. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control;Liu;Chem. Soc. Rev.,2019
3. Photocatalytic Antimicrobials: Principles, Design Strategies, and Applications;Ran;Chem. Rev.,2023
4. GBD 2019 Antimicrobial Resistance Collaborators (2022). Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 400, 2221–2248.
5. Correia, J.H., Rodrigues, J.A., Pimenta, S., Dong, T., and Yang, Z. (2021). Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions. Pharmaceutics, 13.